Mohs surgery

Skin Cancer Management: A Practical Approach

Volumn , Issue , 2010, Pages 143-152

  Ratner, Desiree ^a   MacGregor, Jennifer L ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952742665     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-88495-0_11     Document Type: Chapter

References (36)

1. Mohs FE. Chemosurgery: a microscopically controlled method of cancer excision. Arch Surg. 1941;42:279-295.
2. Drake LA, Dinehart SM, Goltz RW, et al. Guidelines of care for Mohs micrographic surgery. J Am Acad Dermatol. 1995;33:271-278.
3. Rowe DE, Carroll RJ, Day CL. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 1989;15(4):424-431.
4. Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol. 2005;53(3):452-457.
5. Smeets NWJ, Kuijpers DIM, Nelemans P, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face-results of a retrospective study and review of the literature. Br JDermatol. 2004;151:141-147.
6. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol. 1992;26:976-990.
7. Leibovitch I, Huilgol SC, Selva D, et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005;53(2):253-260.
8. Mohs FE. Chemosurgery: microscopically controlled surgery for skin cancer-past, present and future. J Dermatol Surg Oncol. 1978;4:41-54.
9. Mohs FE. Chemosurgery for the microscopically controlled excision of cutaneous cancer. Head Neck Surg. 1978;1:150-163.
10. Robins P, Dzubow LM, Rigel DS. Squamous-cell carcinoma treated by Mohs surgery: an experience with 414 cases in a period of 15 years. J Dermatol Surg Oncol. 1981;7:800-801.
11. Dzubow LM, Rigel DS, Robins P. Risk factors for local recurrence of primary cutaneous squamous cell carcinoma: treatment by microscopically controlled excision. Arch Dermatol. 1982;118:900-902.
12. Holmkvist KA, Roenigk RK. Squamous cell carcinoma of the lip treated with Mohs micrographic surgery: outcome at 5 years. J Am Acad Dermatol. 1998;38:960-966.
13. Mehrany K, Weenig RH, Pittelkow MR, et al. High recurrence rates of squamous cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Dermatol Surg. 2005;31(1):38-42.
14. Kirkorian AY, Moore BL, Siskind J, et al. Perioperative management of anticoagulant therapy during cutaneous surgery: 2005 survey of Mohs surgeons. Dermatol Surg. 2007;33(10):1189-1197.
15. Alcalay J, Alkalay R. Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue? Dermatol Surg. 2004;30(8):1091-1094.
16. Dixon AJ, Dixon MP, Dixon JB. Bleeding complications in skin cancer surgery are associated with warfarin but not aspirin therapy. Br J Surg. 2007;94:1356-1360.
17. Wilson W, Taubert KA, Gewitz M, et al. Prevention of Infective Endocarditis Guidelines From the American Heart Association. Circulation. 2007;116:1736-1754.
18. American Academy of Orthopaedic Surgeons Advisory Statement on Antibiotic Prophylaxis for Dental Patients with Total Joint Replacements. http://www.aaos.org/about/papers/advistmt/1027.asp. Accessed 1/21/09.
19. Wright TI, Baddour LM, Berbari EF, et al. Antibiotic prophylaxis in dermatologic surgery: Advisory statement. J Am Acad Dermatol. 2008;59:464-473.
20. Ratner D, Bagiella E. The efficacy of curettage in delineating margins of basal cell carcinoma before mohs micrographic surgery. Dermatol Surg. 2003;29(9):899-903.
21. Lee DA, Ratner D. Economic impact of preoperative curettage before mohs micrographic surgery for basal cell carcinoma. Dermatol Surg. 2006;32(7):916-923.
22. Huang CC, Boyce S, Northington M, et al. Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micrographic surgery. J Am Acad Dermatol. 2004;51(4):585-591.
23. Chung VQ, Bernardo L, Jiang SB. Presurgical curettage appropriately reduces the number of Mohs stages by better delineating the subclinical extensions of tumor margins. Dermatol Surg. 2005;31(9 Pt 1):1094-1100.
24. Jimenez FJ, Grichnik JM, Buchanan HT, et al. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation. J Am Acad Dermatol. 1995;32:89-94.
25. Jimenez FJ, Grichnik JM, Buchanan MD, et al. Immunohistochemical margin control applied to Mohs micrographic surgical excision of dermatofibrosarcoma protuberans. J Dermatol Surg Oncol. 1994;20(10):687-689.
26. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol. 1997;37(2 Pt 1):236-245.
27. Bricca GM, Brodland DG, Ren D, Zitelli JA. Cutaneous head and neck melanoma treated with Mohs micrographic surgery. J AmAcad Dermatol. 2005 Jan; 52(1):92-100.
28. Hendi A, Brodland DG, Zitelli JA. Melanocytes in longstanding sun-exposed skin-quantitative analysis using the MART-1 immunostain. Arch Dermatol. 2006;142:871-876.
29. Zalla MJ, Lim KK, Dicaudo DJ, Gagnot MM. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg. 2000 Aug; 26(8):771-784.
30. Albertini G, Elston DM, Libow LF, et al. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol Surg. 2002;28(8):656-665.
31. Melanoma clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2004;2:46-60.
32. Walling HW, Scupham RK, Bean AK, et al. Staged excision vs Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 2007 Oct; 57(4):659-664.
33. Johnson TM, Headington JT, Baker SR, et al. Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the "square" procedure. J Am Acad Dermatol. 1997;37:758-764.
34. Hurst EA, Grekin RC, Yu SS, et al. Infectious complications and antibiotic use in dermatologic surgery. Semin Cutan Med Surg. 2007;26(1):47-53.
35. Furoryan T, Grande D. Postoperative wound infection rates in dermatologic surgery. Dermatol Surg. 1995;21(6):509-514.
36. Smack DP, Harrington AC, Dunn C, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment: a randomized controlled trial. JAMA. 1996;25(12):972-977.